POM121L13P

Across TCGA pan-cancer cohorts, POM121L13P RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated POM121L13P data layer.

The strongest signal is observed in kidney chromophobe (KICH), where higher POM121L13P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated POM121L13P expression acts as an unfavorable survival marker.

KICH, LUSC, and THCA are the cancer types where POM121L13P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KICH	DFS	Tertile	All	0.081	0.904	<.001	90	view →
LUSC	OS	Tertile	All	0.166	0.660	.003	72	view →
THCA	DFS	Tertile	All	0.344	0.846	<.001	42	view →
LUAD	OS	Tertile	All	0.444	0.687	.024	27	view →
BLCA	OS	Tertile	All	0.225	0.686	.047	18	view →
PCPG	DFS	Tertile	All	0.167	0.819	.015	9	view →
UCEC	OS	Tertile	III,IV	0.725	0.844	.043	6	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

POM121L13P–KICH (DFS)

Open the KICH breakdown →